Aptose Biosciences
APTO
#10464
Rank
A$6.59 M
Marketcap
A$2.58
Share price
0.00%
Change (1 day)
726.43%
Change (1 year)

Aptose Biosciences (APTO) - Net assets

Net assets on the balance sheet as of March 2025 : -A$11.17 Million

According to Aptose Biosciences's latest financial reports the company has -A$11.17 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Aptose Biosciences - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2023-12-31$-A$4.26 Million-107.68%
2022-12-31$A$55.46 M-45.84%
2021-12-31$A$0.10 B-33.79%
2020-12-31$A$0.15 B15.28%
2019-12-31$A$0.13 B571.17%
2018-12-31$A$19.98 M52.96%
2017-12-31$A$13.06 M28.54%
2016-12-31$A$10.16 M-45.75%
2015-12-31$A$18.73 M
2014-05-31$A$28.16 M-3694.25%
2013-05-31$-A$0.79 Million-61.29%
2012-05-31$-A$2.03 Million-983.9%
2011-05-31$A$0.22 M-137.15%
2010-05-31$-A$0.62 Million-93.48%
2009-05-31$-A$9.46 Million133.06%
2008-05-31$-A$4.06 Million-574.43%
2007-05-31$A$0.85 M-127.55%
2006-05-31$-A$3.11 Million-122.35%
2005-05-31$A$13.88 M-52.76%
2004-05-31$A$29.4 M-9%
2003-05-31$A$32.3 M-36.97%
2002-05-31$A$51.25 M-27.75%
2001-05-31$A$70.93 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Advaxis
ADXS
-A$36.88 Million 230.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Corbus Pharmaceuticals
CRBP
A$0.16 B-1,601.30%๐Ÿ‡บ๐Ÿ‡ธ USA
ImmunoGen
IMGN
A$0.84 B-7,696.32%๐Ÿ‡บ๐Ÿ‡ธ USA